Warby Parker (WRBY)
NYSE Market Closed
Warby Parker Inc. is an eyewear and vision-care company that sells prescription glasses, sunglasses, contact lenses, accessories, and related optical services directly to consumers. The company built its brand around fashionable frames at accessible prices, using a vertically integrated model that combines design, sourcing, retail, e-commerce, and customer service. Its products are sold through physical stores, its website, and mobile apps, giving customers multiple ways to browse frames, complete purchases, and access eye-care services.
The business sits at the intersection of consumer retail, healthcare, and digital commerce. Warby Parker’s omnichannel model is a key part of its identity: customers can use online tools to explore styles, try frames at home in eligible markets, visit stores for fittings or purchases, and in many locations receive eye exams or vision tests. Revenue is primarily generated from eyewear products, including prescription and non-prescription optical frames, sunglasses, contact lenses, and accessories, alongside optical services offered through its retail footprint.
Warby Parker is also associated with a mission-led brand image, including social impact initiatives connected to expanding access to glasses. For investors, WRBY is tied to trends in discretionary consumer spending, store expansion, customer acquisition costs, optical insurance participation, and the broader shift toward branded, direct-to-consumer healthcare retail. Its competitive position depends on maintaining design appeal, convenience, price transparency, and trust in a market that includes traditional optical chains, luxury eyewear groups, online retailers, and independent optometrists.
Last updated
- Market Cap
- 2.97B
- P/E
- 2,208.14
- P/FCF
- 76.4
- P/S
- 3.34
- Enterprise Value
- 2.68B
- Sector
- Health Care
- Industry
- Ophthalmic Goods
- Address
- 233 SPRING STREET, NEW YORK, NY, 10013
Sunglasses Market to hit USD 33.5 billion by 2032, says Global Market Insights Inc.
Earnings Estimates Moving Higher for Warby Parker (WRBY): Time to Buy?
Warby Parker Inc. (WRBY) is a Great Momentum Stock: Should You Buy?
Warby Parker (WRBY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zimmer Biomet (ZBH) Beats Q1 Earnings and Revenue Estimates
Warby Parker’s stock tumbles again after earnings, as gross margins keep falling
Warby Parker Inc. (WRBY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Warby Parker’s stock suffers record selloff as margins were hurt by contact lens sales strength
Toast, Upstart shares sink while Take-Two’s stock rallies — and other stocks on the move
Warby Parker Inc. (WRBY) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Penn Entertainment shares surge on ESPN deal, Lyft slumps and other stocks on the move
Pre-Markets in the Green Ahead of CPI Data Release
Markets Climbing Back; WEN, RBLX, WRBY Report, DIS After the Close
Compared to Estimates, Warby Parker Inc. (WRBY) Q2 Earnings: A Look at Key Metrics
Warby Parker Inc. (WRBY) Q2 Earnings and Revenues Beat Estimates
ResMed (RMD) Misses Q4 Earnings Estimates
Zacks.com featured highlights include Catalyst Pharmaceuticals, Warby Parker, MakeMyTrip Ltd., Brookfield Renewable Partners & Century Aluminum
5 Stocks to Keep a Tab on for Solid Earnings Acceleration
Novavax and Palantir rocket higher, while PayPal slumps and other stocks on the move
Can Last Peak Week of Q1 Earnings Push Growth Into Positive Territory?
- Market Cap
Market cap is the total value of a company's shares, calculated by multiplying the stock price by the number of shares outstanding.
- 2.97B
- Enterprise Value
Enterprise value is the total value of a company, including its market cap, debt, and cash.
- 2.68B
- P/E
P/E ratio compares a company's share price to its earnings per share.
- 2,208.14
- P/B
P/B ratio compares a company's share price to its book value per share.
- 7.91
- P/S
P/S ratio compares a company's share price to its revenue per share.
- 3.34
- EV / EBITDA
EV/EBITDA measures a company's value compared to its earnings before interest, taxes, depreciation, and amortization.
- 54.29
- EV / Sales
EV/Sales measures a company's value compared to its total revenue.
- 3.01
- EPS
- 0.01
- Dividend Yield
Dividend yield shows how much a company pays in dividends each year compared to its share price.
- 0%
- P/FCF
Price-to-free-cash-flow ratio compares a company's share price to the cash it generates after expenses and investments.
- 76.4
- P/CF
P/CF ratio compares a company's share price to the cash flow it generates from its operations.
- 28.06
- Free Cash Flow
Free cash flow is the cash a company has left after covering operating costs and capital expenses.
- 38.9M
- ROE
ROE measures how effectively a company uses shareholders' equity to generate profit.
- 0.36%
- ROA
ROA measures how effectively a company uses its assets to generate profit.
- 0.18%
- Debt / Equity
Debt-to-equity ratio compares a company's total debt to its shareholders' equity.
- 0
- Current Ratio
Current ratio measures a company's ability to pay short-term debts using its short-term assets.
- 2.33
- Quick Ratio
Quick ratio measures a company's ability to pay short-term debts using cash and other easily available assets.
- 2.03
- Cash
Cash ratio measures a company's ability to cover short-term debts using only cash and cash equivalents.
- 1.88
- Avg Volume
Average volume shows the average number of shares traded over the last 30 trading days, helping indicate liquidity.
- 3.06M
- Fundamentals Snapshot Price
Fundamentals snapshot price is the stock price used when calculating the company's financial ratios and metrics.
- 24.22
Income Statement
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Revenue | 242.45M | 211.97M | 221.68M | 214.48M | 223.78M |
| Gross profit | 131.04M | 111.04M | 119.95M | 113.61M | 125.98M |
| Operating income | 1.67M | -6.85M | 3.57M | -4.53M | 2.47M |
| EBITDA | 16.46M | 9.65M | 16.1M | 7.22M | 15.37M |
| Net income | 3.18M | -5.95M | 5.87M | -1.75M | 3.47M |
| Basic EPS | 0.03 | -0.05 | 0.05 | -0.01 | 0.03 |
| Diluted EPS | 0.03 | -0.05 | 0.05 | -0.01 | 0.03 |
Balance Sheet
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Total assets | 736.41M | 720.92M | 706.92M | 701.9M | 682.76M |
| Total liabilities | 360.6M | 353.19M | 337.3M | 340.45M | 328.67M |
| Total equity | 375.81M | 367.73M | 369.63M | 361.45M | 354.09M |
| Cash & equivalents | 288.25M | 286.36M | 280.36M | 286.38M | 265.07M |
| Current assets | 357.69M | 352.44M | 344.06M | 346.1M | 330.6M |
| Current liabilities | 153.28M | 150.13M | 132.07M | 135.53M | 122.61M |
Cash Flow
| Line Item | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| Operating cash flow | 24.51M | 23.25M | 17.97M | 40.2M | 29.36M |
| Investing cash flow | -16.14M | -15.12M | -19.49M | -16.29M | -16.15M |
| Financing cash flow | -6.16M | -2.31M | -4.61M | -2.77M | -2.3M |
| Change in cash | 1.89M | 6M | -6.02M | 21.31M | 10.91M |
| Kind | Filing | Date | Link |
|---|---|---|---|
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| edgar index | 144 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — SINGER BRADLEY E | View Filing | |
| edgar index | 144 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — SINGER BRADLEY E | View Filing | |
| form 4 | Form 4 — SINGER BRADLEY E | View Filing | |
| edgar index | 8-K — Warby Parker Inc. | View Filing | |
| edgar index | 10-Q — Warby Parker Inc. | View Filing | |
| eight k text | 8-K — 8-K | View Filing | |
| edgar index | SCHEDULE 13G — Warby Parker Inc. | View Filing | |
| edgar index | DEF 14A — Warby Parker Inc. | View Filing | |
| edgar index | DEFA14A — Warby Parker Inc. | View Filing | |
| edgar index | ARS — Warby Parker Inc. | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| edgar index | 144 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| edgar index | 144 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| edgar index | SCHEDULE 13G/A — Warby Parker Inc. | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| edgar index | 144 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Raider Jeffrey Jacob | View Filing | |
| form 4 | Form 4 — Raider Jeffrey Jacob | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| edgar index | 4 — Warby Parker Inc. | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Gilboa David Abraham | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing | |
| form 4 | Form 4 — Blumenthal Neil Harris | View Filing |